Trials / Unknown
UnknownNCT06347783
Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes
The Effect of Automated Insulin Delivery on Sleep Compared to Multiple Daily Injections in Pediatric Patients With Type 1 Diabetes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. We are hoping to find out if insulin pumps improve sleep, worsen sleep, or have no effect at all. We are hoping to also explore the relationship between insulin pumps, sleep, and overnight blood sugar control. Your information will not be stored and used for future research. The goal of this observational study is learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. The main questions it aims to answer are: Do insulin pumps improve sleep, worsen sleep or have no effect at all? What is the relationship between insulin pumps, sleep, and overnight blood sugar control? Participants will be asked to: * Complete questionnaires regarding demographic data and diabetes history. * Complete surveys regarding sleep quality before and after starting an insulin pump. * Wear a FitBit during sleep for 2 weeks and fill out daily sleep diaries over a 2 week period prior to starting an insulin pump. After 1-2 months after initiation of an insulin pump, participants will be asked again to: * Complete surveys regarding sleep quality * Wear a FitBit during sleep for 2 weeks * Fill out daily sleep diaries over the same 2 week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Insulin pump | Continuous subcutaneous insulin therapy. |
Timeline
- Start date
- 2024-05-15
- Primary completion
- 2024-11-15
- Completion
- 2024-12-15
- First posted
- 2024-04-04
- Last updated
- 2024-04-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06347783. Inclusion in this directory is not an endorsement.